TRANSCRIPTOME ANALYSIS AND SORAFENIB EFFECTS ON HGF/CMET PATHWAY IN LIVER CANCER CELL LINES

被引:0
|
作者
Piscaglia, Anna C. [1 ]
Saulnier, Nathalie [1 ]
Barba, Marta [1 ]
Castellini, Laura [1 ]
Tesori, Valentina [1 ]
Campanale, Mariachiara [1 ]
Purchiaroni, Flaminia [1 ]
Cesario, Valentina [1 ]
Galeotti, Tommaso [1 ]
Pani, Giovanbattista [1 ]
Gasbarrini, Antonio [1 ]
机构
[1] Univ Cattolica Sacro Cuore, Rome, Italy
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1810
引用
收藏
页码:1140A / 1140A
页数:1
相关论文
共 50 条
  • [21] Transcriptome analysis of HERV-K env knockout ovarian cancer cell lines
    Lee, Seul Yi
    Kim, So Hee
    Jung, Ha Eun
    Yoon, Hyung Joon
    Ha, Hyeong In
    Song, Yong Jung
    Suh, Dong Soo
    Kim, Ki Hyung
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A87 - A88
  • [22] Transcriptome Analysis of Liver Cancer Cell Huh-7 Treated With Metformin
    Li, Chun-Qing
    Liu, Zhi-Qin
    Liu, Sha-Sha
    Zhang, Gao-Tao
    Jiang, Li
    Chen, Chuan
    Luo, Du-Qiang
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [23] Proteomic changes in colorectal cancer cell lines in response to sorafenib treatment
    Auer, T.
    Gamerith, G.
    Sarg, B.
    Mueller, D.
    Zwierzina, H.
    Lindner, H.
    Hilbe, W.
    Loeffler-Ragg, J.
    EJC SUPPLEMENTS, 2009, 7 (04): : 34 - 34
  • [24] Mechanism of antitumor effect of Sorafenib in anaplastic thyroid cancer cell lines
    Ishihara, Sae
    CANCER RESEARCH, 2019, 79 (13)
  • [25] Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines
    Holland, William S.
    Chinn, Danielle C.
    Lara, Primo N., Jr.
    Gandara, David R.
    Mack, Philip C.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2015, 141 (04) : 615 - 626
  • [26] Somatic mutations in human cancer cell lines predict sorafenib response
    Rhodes, Daniel R.
    Kaufmann, Scott H.
    Meng, Xue Wei
    Wyngaard, Peter
    Leopold, Judith S.
    MOLECULAR CANCER THERAPEUTICS, 2009, 8 (12)
  • [27] Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
    Nakagawa, Shigeki
    Wei, Lan
    Song, Won Min
    Higashi, Takaaki
    Ghoshal, Sarani
    Kim, Rosa S.
    Bian, C. Billie
    Yamada, Suguru
    Sun, Xiaochen
    Venkatesh, Anu
    Goossens, Nicolas
    Bain, Gretchen
    Lauwers, Gregory Y.
    Koh, Anna P.
    El-Abtah, Mohamed
    Ahmad, Noor B.
    Hoshida, Hiroki
    Erstad, Derek J.
    Gunasekaran, Ganesh
    Lee, Youngmin
    Yu, Ming-Lung
    Chuang, Wan-Long
    Dai, Chia-Yen
    Kobayashi, Masahiro
    Kumada, Hiromitsu
    Beppu, Toru
    Baba, Hideo
    Mahajan, Milind
    Nair, Venugopalan D.
    Lanuti, Michael
    Villanueva, Augusto
    Sangiovanni, Angelo
    Iavarone, Massimo
    Colombo, Massimo
    Llovet, Josep M.
    Subramanian, Aravind
    Tager, Andrew M.
    Friedman, Scott L.
    Baumert, Thomas F.
    Schwarz, Myron E.
    Chung, Raymond T.
    Tanabe, Kenneth K.
    Zhang, Bin
    Fuchs, Bryan C.
    Hoshida, Yujin
    CANCER CELL, 2016, 30 (06) : 879 - 890
  • [28] Effects of AKT inhibition on HGF-mediated erlotinib resistance in non-small cell lung cancer cell lines
    William S. Holland
    Danielle C. Chinn
    Primo N. Lara
    David R. Gandara
    Philip C. Mack
    Journal of Cancer Research and Clinical Oncology, 2015, 141 : 615 - 626
  • [29] Transcriptome Analysis of Cell Lines Established from An Oval-Cell Derived Hepatic Tumor: Assessment of a Functional Signature Underlying Liver Cancer Progression
    Piscaglia, Anna C.
    Saulnier, Nathalie
    Tesori, Valentina
    Barba, Marta
    Campanale, Mariachiara
    Cesario, Valentina
    Purchiaroni, Flaminia
    Ianiro, Gianluca
    Galeotti, Tommaso
    Petersen, Bryon E.
    Pani, Giovambattista
    Gasbarrini, Antonio
    GASTROENTEROLOGY, 2009, 136 (05) : A857 - A857
  • [30] Met and HGF inhibition in triple-negative breast cancer cell lines
    Gaule, Patricia Brid
    Collins, Denis
    Walsh, Naomi
    Duffy, Michael J.
    Crown, John
    O'Donovan, Norma
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)